ClinicalThought
Thoughts on Recent Advances With Precision Medicine in Cervical Cancer
Release Date: May 31, 2022
Expiration Date: May 30, 2023
Not certified for credit.
Begin »
Program Overview
Program Description
Read this commentary from Ritu Salani, MD, MBA, and Rachel Frankenthal, PA-C, MPH, to learn about recent advances in precision medicine for cervical cancer.
Format
Clinical Thought
Target Audience
NPs and PAs in oncology
Faculty
Rachel Frankenthal, PA-C, MPH
- Physician Assistant
- Division of Gynecologic Oncology
- Department of Obstetrics and Gynecology
- University of California, Los Angeles
- Los Angeles, California
Ritu Salani, MD, MBA
- Professor and Division Director
- Division of Gynecologic Oncology
- Department of Obstetrics and Gynecology
- University of California, Los Angeles
- Los Angeles, California
Details
This activity is supported by educational grants from AstraZeneca; GlaxoSmithKline; and Merck Sharp & Dohme Corp.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
Rachel Frankenthal, PA-C, MPH has no relevant financial relationships to disclose.
Ritu Salani, MD, MBA: consultant/advisor/speaker: Arcus Biosciences, Genentech, GlaxoSmithKline, Instil Bio, Merck, Regeneron, Seagen.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 104922O-CT7